这是一篇来自已证抗体库的有关
人类 CYP1A2的综述,是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CYP1A2 抗体。
CYP1A2 同义词: CP12; CYPIA2; P3-450; P450(PA)
圣克鲁斯生物技术
小鼠 单克隆(d15) | - 免疫组化-石蜡切片; 小鼠; 1:100; 图 2a
- 免疫印迹; 小鼠; 1:1000; 图 2b
| 圣克鲁斯生物技术 CYP1A2抗体(Santa Cruz, sc-53241)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 2a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2b). Cell Rep Med (2022) ncbi |
小鼠 单克隆(d15) | - 免疫组化-石蜡切片; 人类; 1:200; 图 8g
- 免疫细胞化学; 人类; 1:200; 图 6s1d
| 圣克鲁斯生物技术 CYP1A2抗体(Santa Cruz, sc-53241)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 8g) 和 被用于免疫细胞化学在人类样本上浓度为1:200 (图 6s1d). elife (2019) ncbi |
小鼠 单克隆 | | 圣克鲁斯生物技术 CYP1A2抗体(SantaCruz, sc-393783)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6h). Biochem Pharmacol (2017) ncbi |
小鼠 单克隆(d15) | | 圣克鲁斯生物技术 CYP1A2抗体(SantaCruz, sc-53241)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 10a). Drug Metab Dispos (2017) ncbi |
小鼠 单克隆(3B8C1) | | 圣克鲁斯生物技术 CYP1A2抗体(Santa Cruz, sc-53614)被用于被用于免疫印迹在人类样本上 (图 6b). Toxicol Lett (2016) ncbi |
小鼠 单克隆(d15) | | 圣克鲁斯生物技术 CYP1A2抗体(Santa Cruz, SC-53241)被用于被用于免疫印迹在人类样本上 (图 2). PLoS ONE (2016) ncbi |
小鼠 单克隆(3B8C1) | | 圣克鲁斯生物技术 CYP1A2抗体(Santa Cruz Biotechnology, sc-53614)被用于被用于免疫印迹在人类样本上. Biotechnol Bioeng (2013) ncbi |
艾博抗(上海)贸易有限公司
小鼠 单克隆(3B8C1) | | 艾博抗(上海)贸易有限公司 CYP1A2抗体(Abcam, 3B8C1)被用于被用于免疫组化在人类样本上浓度为1:1000 (图 4a). Sci Rep (2022) ncbi |
domestic rabbit 单克隆(EPR6138(2)) | - 免疫组化; common marmoset; 图 6
| 艾博抗(上海)贸易有限公司 CYP1A2抗体(Abcam, ab151728)被用于被用于免疫组化在common marmoset样本上 (图 6). Hepat Med (2020) ncbi |
赛默飞世尔
domestic rabbit 多克隆 | | 赛默飞世尔 CYP1A2抗体(ThermoFisher, PA1-341)被用于被用于免疫印迹在人类样本上 (图 1d). Toxicol In Vitro (2017) ncbi |
Hu S, Liu S, Bian Y, Poddar M, Singh S, Cao C,
et al. Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep Med. 2022;3:100754
pubmed 出版商
Uehara S, Iida Y, Ida Tanaka M, Goto M, Kawai K, Yamamoto M,
et al. Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism. Sci Rep. 2022;12:14907
pubmed 出版商
Aravalli R, COLLINS D, Hapke J, Crane A, Steer C. Hepatic Differentiation of Marmoset Embryonic Stem Cells and Functional Characterization of ESC-Derived Hepatocyte-Like Cells. Hepat Med. 2020;12:15-27
pubmed 出版商
Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K,
et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8:
pubmed 出版商
Chen Y, Zeng L, Wang Y, Tolleson W, Knox B, Chen S,
et al. The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5p. Biochem Pharmacol. 2017;145:178-191
pubmed 出版商
Cheng S, Bammler T, Cui J. RNA Sequencing Reveals Age and Species Differences of Constitutive Androstane Receptor-Targeted Drug-Processing Genes in the Liver. Drug Metab Dispos. 2017;45:867-882
pubmed 出版商
Vogel K, Ainslie G, Roullet J, McConnell A, Gibson K. In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of ?-hydroxybutyrate (GHB) binding. Toxicol In Vitro. 2017;40:196-202
pubmed 出版商
Štěpánková M, Krasulová K, Doricakova A, Kurka O, Anzenbacher P, Dvorak Z. Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450. Toxicol Lett. 2016;262:173-186
pubmed 出版商
Rasmussen M, Balaguer P, Ekstrand B, Daujat Chavanieu M, Gerbal Chaloin S. Skatole (3-Methylindole) Is a Partial Aryl Hydrocarbon Receptor Agonist and Induces CYP1A1/2 and CYP1B1 Expression in Primary Human Hepatocytes. PLoS ONE. 2016;11:e0154629
pubmed 出版商
Yang Y, Li J, Pan X, Zhou P, Yu X, Cao H,
et al. Co-culture with mesenchymal stem cells enhances metabolic functions of liver cells in bioartificial liver system. Biotechnol Bioeng. 2013;110:958-68
pubmed 出版商